Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein carbonylation is an irreversible oxidative post-translational modification in which proteins acquire reactive carbonyl groups (aldehydes, ketones) after exposure to reactive oxygen species, lipid peroxidation products, or reactive sugars via glycation[1][2][3][4]. These modifications alter protein structure and function, marking them for degradation and contributing to cellular aging, chronic disease, inflammatory processes, and oxidative stress conditions[2][3][4][5]. Carbonylated proteins and their levels serve as biomarkers of oxidative damage and stress; they are detectable via specific assays and may be targeted by antioxidants or carbonyl scavengers in therapeutic research[1][3][5].
Scavenging reactive carbonyl species to prevent protein modification\nInhibiting glycation or oxidative pathways producing carbonyls
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein carbonylation process.